Company intelligence / Profile preview

Dialysis-X

Boston, Massachusetts, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Dialysis-X is an early-stage private medical device company developing a needle-free vascular access solution for hemodialysis patients. Its product concept is designed to replace or reduce conventional needle cannulation by combining an implanted component with an external cap or access interface. The company is focused on improving safety, comfort, and usability for dialysis treatment in both clinic and home settings. Based on available public information, Dialysis-X appears to be a startup founded in 2021 in the Boston area and is still in the development stage rather than commercial stage. The company operates in the kidney care and dialysis device segment rather than as a therapeutics developer.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Dialysis-X.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dialysis-X.

Explore the full profile